Literature DB >> 858010

Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.

A H Drummond, D E MacIntyre, H J Olverman.   

Abstract

Aspirin at therapeutic concentrations does not inhibit the uptake of 5-hydroxytryptamine (5-HT) by blood platelets nor induce release of 5-HT from platelets, although platelet aggregation responses to collagen and arachidonic acid (which are dependent on platelet prostaglandin synthesis) are abolished. This does not support an earlier claim that aspirin's effects on platelet function include inhibition of 5-HT transport.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 858010      PMCID: PMC1667754          DOI: 10.1111/j.1476-5381.1977.tb07735.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  4 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Uptake of 5-hydroxytryptamine by rat blood platelets and its inhibition by adenosine 5'-diphosphate.

Authors:  A H Drummond; J L Gordon
Journal:  Br J Pharmacol       Date:  1976-04       Impact factor: 8.739

3.  The effect of aspirin on 5-hydroxytryptamine uptake and release by human platelets.

Authors:  F Rendu
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

4.  A simple fluorimetric microassay for adenine compounds in platelets and plasma and its application to studies on the platelet release reaction.

Authors:  J L Gordon; A H Drummond
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.